Investigations into lethal patient abuse by the thorax surgeon and regenerative medicine “pioneer” Paolo Macchiarini are now concluded in Stockholm. The Karolinska University Hospital (Karolinska Universitetssjukhuset, KS) published their investigative report on August 31st, the Karolinska Insitutet (KI) will follow with theirs on September 5th.
The KS investigation was chaired by Kjell Asplund, emeritus professor in medicine at Umeå University, who is also chairman of the Swedish Council on Medical Ethics (Smer) and former director-general of the National Board of Health and Welfare (Socialstyrelsen). The Asplund report found gross violations of medical ethics, patient right, even recruitment processes when analysing the history of the scandal around the Italian surgeon. Unlike repeatedly declared by both KI and KS, Macchiarini’s trachea transplants were not medical emergencies and not compassionate care cases:
“There was no immediate threat to the life of any of the three transplant patients before the operations”.
Unethical research, not humanitarian care
These interventions were now determined as clinical research and as such were supposed to be subject to ethics vote and medicinal product approval. This in stark contrast to previous declarations by KI and KS leadership, namely that Macchiarini’s trachea transplants were merely humanitarian care and medical emergencies. Now the Asplund workgroup rebukes in their Swedish-language report:
“We question the hospital’s stubborn position in defence of transplants’ clean health care initiatives”.